Antitrust Group Says Mallinckrodt Plan Lacks Sufficient Votes
A group with antitrust claims against drugmaker Mallinckrodt challenged the vote approving the company's Chapter 11 plan on Tuesday, but lost a bid to get counsel for the unsecured creditors on...To view the full article, register now.
Already a subscriber? Click here to view full article